Europe

HSBC has named Jackson Tai, the former Asia Pacific chairman of JP Morgan and chief executive officer of DBS, as an independent non-executive director of its board.

Icap has promoted a senior official to run its EBS BrokerTec fixed income electronic trading division.

The European corporate bond market stalled on Monday as autumn supply widened in sympathy with volatile government bond markets.

UniCredit announced three senior appointments in its corporate and investment banking (CIB) division on Monday, naming a new head of CIB Americas, a head of CIB Italy network, and a head of financing and advisory Italy.

The last round of IMF lending to developed market countries (before the European sovereign crisis) was 40 years ago this autumn — when Britain was locked out of the capital markets and had to go ‘cap in hand’ to the Fund.

Canada Pension Plan Investment Board will sell its first ever bond on Tuesday, and HSH Finanzfonds mandated what will be its longest dated bond ever.

Bank Nederlandse Gemeenten has kicked the week off with a long dated tap in euros and a mandate for a follow-up two year dollar benchmark, which will share Tuesday's market with two other dollar trades.

Shares in Hamborner Reit, the German real estate investment trust, fell by as much as 8.3% on Tuesday morning after the company said it would try to raise up to €166.5m, though a seven-for-two rights issue to finance the acquisition of new properties.

German healthcare group Fresenius has mandated three banks to provide a bridge loan for its €5.76bn acquisition of Spain’s largest private hospital group, Quirónsalud, and may add a fourth, according to a banker close to the deal.

German real estate firm VIB Vermoegen is in the market for a €60m Schuldschein. Not only is a property borrower a rare sight in the market but the deal also raises questions about the subordination of Schuldschein debt.

German automotive parts manufacturer Ifa Rotorion grew its Schuldschein from €100m to €140m in syndication, reaching the maximum amount the borrower was willing to take, according to one banker.

Adienne Pharma & Biotech, the Swiss pharmaceutical company specialising in treatments for orphan diseases, has announced its intention to float on the SIX Swiss Exchange.